Authors:
GEORGE SJ
JOHNSON JL
ANGELINI GD
NEWBY AC
BAKER AH
Citation: Sj. George et al., ADENOVIRUS-MEDIATED GENE-TRANSFER OF THE HUMAN TIMP-1 GENE INHIBITS SMOOTH-MUSCLE CELL-MIGRATION AND NEOINTIMAL FORMATION IN HUMAN SAPHENOUS-VEIN, Human gene therapy, 9(6), 1998, pp. 867-877
Citation: Sj. George et al., GENE-TRANSFER OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 INHIBITS METALLOPROTEINASE ACTIVITY AND NEOINTIMA FORMATION IN HUMAN SAPHENOUS VEINS, Gene therapy, 5(11), 1998, pp. 1552-1560
Citation: M. Ahonen et al., ADENOVIRUS-MEDIATED DELIVERY OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 GENES INHIBITS INVASION OF METASTATIC MELANOMA-CELLS, Journal of investigative dermatology, 110(4), 1998, pp. 718-718
Citation: Ah. Baker et al., DIVERGENT EFFECTS OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, OR METALLOPROTEINASE-3 OVEREXPRESSION ON RAT VASCULAR SMOOTH-MUSCLE CELL INVASION, PROLIFERATION, AND DEATH IN-VITRO - TIMP-3 PROMOTES APOPTOSIS, The Journal of clinical investigation, 101(6), 1998, pp. 1478-1487
Citation: M. Bond et al., SYNERGISTIC UP-REGULATION OF METALLOPROTEINASE-9 BY GROWTH-FACTORS AND INFLAMMATORY CYTOKINES - AN ABSOLUTE REQUIREMENT FOR TRANSCRIPTION FACTOR NF-KAPPA-B, FEBS letters, 435(1), 1998, pp. 29-34
Citation: M. Ahonen et al., ADENOVIRUS-MEDIATED GENE DELIVERY OF TISSUE INHIBITOR OF METALLOPROTEINASES-3 INHIBITS INVASION AND INDUCES APOPTOSIS IN MELANOMA-CELLS, Cancer research, 58(11), 1998, pp. 2310-2315
Citation: Am. Mcelligott et al., THE EFFECT OF ADENOVIRAL GENE-TRANSFER OF MMP AND TIMP ON A RENAL-CELL LINE, British Journal of Cancer, 78, 1998, pp. 55-55
Citation: D. Armstrong et Ah. Baker, HEALTH-CARE PROVIDERS VIEWS ABOUT AN URBAN-COMMUNITY HOSPITAL, Health & social care in the community, 5(5), 1997, pp. 347-350
Citation: M. Ahonen et al., HIGH-LEVEL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 IN MELANOMA-CELLS ACHIEVED BY ADENOVIRUS-MEDIATED GENE DELIVERY, Cancer gene therapy, 4(5), 1997, pp. 299-299
Citation: Am. Mcelligott et al., TISSUE INHIBITOR OF METALLOPROTEINASE GENE-EXPRESSION - A TARGET FOR GENE-THERAPY IN RENAL-CELL CARCINOMA, Cancer gene therapy, 4(5), 1997, pp. 300-300
Citation: M. Ahonen et al., HIGH-LEVEL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 IN MELANOMA-CELLS ACHIEVED BY ADENOVIRUS-MEDIATED GENE-TRANSFER, Journal of investigative dermatology, 109(3), 1997, pp. 416-416
Authors:
BAKER AH
WILKINSON GWG
HEMBRY RM
MURPHY G
NEWBY AC
Citation: Ah. Baker et al., DEVELOPMENT OF RECOMBINANT ADENOVIRUSES THAT DRIVE HIGH-LEVEL EXPRESSION OF THE HUMAN METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 AND METALLOPROTEINASE-2 GENES - CHARACTERIZATION OF THEIR INFECTION INTO RABBIT SMOOTH-MUSCLE CELLS AND HUMAN MCF-7 ADENOCARCINOMA CELLS, Matrix biology, 15(6), 1996, pp. 383-395
Authors:
FABUNMI RP
BAKER AH
MURRAY EJ
BOOTH RFG
NEWBY AC
Citation: Rp. Fabunmi et al., DIVERGENT REGULATION BY GROWTH-FACTORS AND CYTOKINES OF 95-KDA AND 72-KDA GELATINASES AND TISSUE INHIBITORS OF METALLOPROTEINASE-1, METALLOPROTEINASE-2 AND METALLOPROTEINASE-3 IN RABBIT AORTIC SMOOTH-MUSCLE CELLS, Biochemical journal, 315, 1996, pp. 335-342
Authors:
SOUTHGATE KM
FISHER M
BANNING AP
THURSTON VJ
BAKER AH
FABUNMI RP
GROVES PH
DAVIES M
NEWBY AC
Citation: Km. Southgate et al., UP-REGULATION OF BASEMENT MEMBRANE-DEGRADING METALLOPROTEINASE SECRETION AFTER BALLOON INJURY OF PIG CAROTID ARTERIES, Circulation research, 79(6), 1996, pp. 1177-1187
Authors:
TAYLOR C
MCGLYNN H
CARTER G
BAKER AH
WARREN N
RIDGE SA
OWEN G
THOMPSON E
THOMPSON PW
JACOBS A
PADUA RA
Citation: C. Taylor et al., RAS AND FMS MUTATIONS FOLLOWING CYTOTOXIC THERAPY FOR CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA, Leukemia, 9(3), 1995, pp. 466-470
Authors:
BAKER AH
CACHIA PG
TENNANT GB
WHITTAKER JA
WHITE D
STANLEY ER
BURNETT AK
PADUA RA
Citation: Ah. Baker et al., A NOVEL CSF-1 BINDING-FACTOR IN A PATIENT IN COMPLETE REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA, British Journal of Haematology, 89(1), 1995, pp. 219-222
Authors:
MCGLYNN H
BAKER AH
RIDGE SA
CACHIA PG
WHITTAKER JA
BURNETT AK
PADUA RA
Citation: H. Mcglynn et al., FMS MUTATIONS IN PATIENTS IN REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA AND CHILDHOOD LEUKEMIA, Blood, 82(10), 1993, pp. 10000035-10000035